Skip to main content
Erschienen in: International Journal of Colorectal Disease 1/2017

10.10.2016 | Original Article

CONUT: a novel independent predictive score for colorectal cancer patients undergoing potentially curative resection

verfasst von: Ryuma Tokunaga, Yasuo Sakamoto, Shigeki Nakagawa, Mayuko Ohuchi, Daisuke Izumi, Keisuke Kosumi, Katsunobu Taki, Takaaki Higashi, Yuji Miyamoto, Naoya Yoshida, Eiji Oki, Masayuki Watanabe, Hideo Baba

Erschienen in: International Journal of Colorectal Disease | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Controlling nutritional status (CONUT) score, calculated from serum albumin and total cholesterol concentrations and total lymphocyte count, is reportedly valuable for nutritional assessment. This study investigated whether CONUT score was predictive of outcomes in colorectal cancer (CRC) patients undergoing surgical resection.

Methods

Preoperative CONUT scores were retrospectively evaluated in 417 CRC patients who underwent potentially curative resection at Kumamoto University Hospital from March 2005 to August 2014. Patients were divided into four groups based on preoperative CONUT scores: normal, light, moderate, and severe. The associations of CONUT score with clinicopathological factors, patient survival, and postoperative complications were examined.

Results

CONUT score correlated significantly with age (P < 0.001), body mass index (P = 0.005), carcinoembryonic antigen (P = 0.002), and carbohydrate antigen 19-9 (P = 0.005) concentrations. Overall survival (OS) rate was significantly lower in patients with moderate/severe than light or normal CONUT scores. CONUT score was independently prognostic of OS [moderate/severe vs. normal, hazard ratio = 5.92, 95 % confidence interval (CI) 2.30–14.92; P < 0.001)]. Patients with moderate/severe CONUT scores were at greater risk for complications, especially for severe complications. Multivariate analysis showed that CONUT score was independently predictive of severe complications (moderate/severe vs. normal, odds ratio = 4.51, 95 % CI 1.89–10.74; P < 0.001).

Conclusions

CONUT score may predict survival and postoperative severe complications in CRC patients undergoing potentially curative resection. Management of CRC patients may need consideration of host nutritional status.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Bistrian BR, Blackburn GL, Vitale J, Cochran D, Naylor J (1976) Prevalence of malnutrition in general medical patients. JAMA 235:1567–1570CrossRefPubMed Bistrian BR, Blackburn GL, Vitale J, Cochran D, Naylor J (1976) Prevalence of malnutrition in general medical patients. JAMA 235:1567–1570CrossRefPubMed
2.
Zurück zum Zitat Gupta D, Lammersfeld CA, Vashi PG, Burrows J, Lis CG, Grutsch JF (2005) Prognostic significance of subjective global assessment (SGA) in advanced colorectal cancer. Eur J Clin Nutr 59:35–40CrossRefPubMed Gupta D, Lammersfeld CA, Vashi PG, Burrows J, Lis CG, Grutsch JF (2005) Prognostic significance of subjective global assessment (SGA) in advanced colorectal cancer. Eur J Clin Nutr 59:35–40CrossRefPubMed
3.
Zurück zum Zitat Mohri Y, Inoue Y, Tanaka K, Hiro J, Uchida K, Kusunoki M (2013) Prognostic nutritional index predicts postoperative outcome in colorectal cancer. World J Surg 37:2688–2692CrossRefPubMed Mohri Y, Inoue Y, Tanaka K, Hiro J, Uchida K, Kusunoki M (2013) Prognostic nutritional index predicts postoperative outcome in colorectal cancer. World J Surg 37:2688–2692CrossRefPubMed
4.
Zurück zum Zitat Park JH, Watt DG, Roxburgh CS, Horgan PG, McMillan DC (2015) Colorectal cancer, systemic inflammation, and outcome: staging the tumor and staging the host. Ann Surg 263(2):326–336CrossRef Park JH, Watt DG, Roxburgh CS, Horgan PG, McMillan DC (2015) Colorectal cancer, systemic inflammation, and outcome: staging the tumor and staging the host. Ann Surg 263(2):326–336CrossRef
5.
Zurück zum Zitat Ignacio de Ulibarri J, Gonzalez-Madrono A, de Villar NG, Gonzalez P, Gonzalez B, Mancha A, Rodriguez F, Fernandez G (2005) CONUT: a tool for controlling nutritional status. First validation in a hospital population. Nutr Hosp 20:38–45PubMed Ignacio de Ulibarri J, Gonzalez-Madrono A, de Villar NG, Gonzalez P, Gonzalez B, Mancha A, Rodriguez F, Fernandez G (2005) CONUT: a tool for controlling nutritional status. First validation in a hospital population. Nutr Hosp 20:38–45PubMed
6.
Zurück zum Zitat The Japanese Society for Cancer of the Colon and Rectum. JSCCR Guidelines 2005 for the treatment of colorectal cancer. Tokyo: Kanehara & Co, Ltd. The Japanese Society for Cancer of the Colon and Rectum. JSCCR Guidelines 2005 for the treatment of colorectal cancer. Tokyo: Kanehara & Co, Ltd.
7.
Zurück zum Zitat The Japanese Society for Cancer of the Colon and Rectum. JSCCR Guidelines 2010 for the treatment of colorectal cancer. Tokyo: Kanehara & Co, Ltd The Japanese Society for Cancer of the Colon and Rectum. JSCCR Guidelines 2010 for the treatment of colorectal cancer. Tokyo: Kanehara & Co, Ltd
8.
Zurück zum Zitat Watanabe T, Itabashi M, Shimada Y, Tanaka S, Ito Y, Ajioka Y, Hamaguchi T, Hyodo I, Igarashi M, Ishida H, Ishiguro M, Kanemitsu Y et al (2012) Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer. Int J Clin Oncol 17:1–29CrossRefPubMed Watanabe T, Itabashi M, Shimada Y, Tanaka S, Ito Y, Ajioka Y, Hamaguchi T, Hyodo I, Igarashi M, Ishida H, Ishiguro M, Kanemitsu Y et al (2012) Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer. Int J Clin Oncol 17:1–29CrossRefPubMed
9.
Zurück zum Zitat Sobin LH, Gospodarowitz MK, Wittekind CH (2009) TNM classification of malignant tumours. 7th ed. Wiley-Blackwell, New York Sobin LH, Gospodarowitz MK, Wittekind CH (2009) TNM classification of malignant tumours. 7th ed. Wiley-Blackwell, New York
10.
Zurück zum Zitat Cabre M, Ferreiro C, Arus M, Roca M, Palomera E, Serra-Prat M (2015) Evaluation of CONUT for clinical malnutrition detection and short-term prognostic assessment in hospitalized elderly people. J Nutr Health Aging 19:729–733CrossRefPubMed Cabre M, Ferreiro C, Arus M, Roca M, Palomera E, Serra-Prat M (2015) Evaluation of CONUT for clinical malnutrition detection and short-term prognostic assessment in hospitalized elderly people. J Nutr Health Aging 19:729–733CrossRefPubMed
11.
Zurück zum Zitat Tarantino I, Warschkow R, Worni M, Merati-Kashani K, Koberle D, Schmied BM, Muller SA, Steffen T, Cerny T, Guller U (2012) Elevated preoperative CEA is associated with worse survival in stage I-III rectal cancer patients. Br J Cancer 107:266–274CrossRefPubMedPubMedCentral Tarantino I, Warschkow R, Worni M, Merati-Kashani K, Koberle D, Schmied BM, Muller SA, Steffen T, Cerny T, Guller U (2012) Elevated preoperative CEA is associated with worse survival in stage I-III rectal cancer patients. Br J Cancer 107:266–274CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Stiksma J, Grootendorst DC, van der Linden PW (2014) CA 19-9 as a marker in addition to CEA to monitor colorectal cancer. Clin Colorectal Cancer 13:239–244CrossRefPubMed Stiksma J, Grootendorst DC, van der Linden PW (2014) CA 19-9 as a marker in addition to CEA to monitor colorectal cancer. Clin Colorectal Cancer 13:239–244CrossRefPubMed
13.
Zurück zum Zitat Fukushima K, Ueno Y, Kawagishi N, Kondo Y, Inoue J, Kakazu E, Ninomiya M, Wakui Y, Saito N, Satomi S, Shimosegawa T (2014) The nutritional index ‘CONUT’ is useful for predicting long-term prognosis of patients with end-stage liver diseases. Tohoku J Exp Med 224:215–219CrossRef Fukushima K, Ueno Y, Kawagishi N, Kondo Y, Inoue J, Kakazu E, Ninomiya M, Wakui Y, Saito N, Satomi S, Shimosegawa T (2014) The nutritional index ‘CONUT’ is useful for predicting long-term prognosis of patients with end-stage liver diseases. Tohoku J Exp Med 224:215–219CrossRef
14.
Zurück zum Zitat Elinav E, Nowarski R, Thaiss CA, Hu B, Jin C, Flavell RA (2013) Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer 13:759–771CrossRefPubMed Elinav E, Nowarski R, Thaiss CA, Hu B, Jin C, Flavell RA (2013) Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer 13:759–771CrossRefPubMed
15.
Zurück zum Zitat Renfro LA, Loupakis F, Adams RA, Seymour MT, Schmoll HJ, Douillard JY, Hurwitz H, Fuchs CS, Diaz-Rubio E, Porschen R, Tournigand C, Chibaudel B et al (2015) Body mass index is prognostic in metastatic colorectal cancer: pooled analysis of patients from first-line clinical trials in the ARCAD database. J Clin Oncol 34(2):144–150CrossRefPubMedPubMedCentral Renfro LA, Loupakis F, Adams RA, Seymour MT, Schmoll HJ, Douillard JY, Hurwitz H, Fuchs CS, Diaz-Rubio E, Porschen R, Tournigand C, Chibaudel B et al (2015) Body mass index is prognostic in metastatic colorectal cancer: pooled analysis of patients from first-line clinical trials in the ARCAD database. J Clin Oncol 34(2):144–150CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Moon HG, YT J, Jeong CY, Jung EJ, Lee YJ, Hong SC, Ha WS, Park ST, Choi SK (2008) Visceral obesity may affect oncologic outcome in patients with colorectal cancer. Ann Surg Oncol 15:1918–1922CrossRefPubMed Moon HG, YT J, Jeong CY, Jung EJ, Lee YJ, Hong SC, Ha WS, Park ST, Choi SK (2008) Visceral obesity may affect oncologic outcome in patients with colorectal cancer. Ann Surg Oncol 15:1918–1922CrossRefPubMed
17.
Zurück zum Zitat Miyamoto Y, Baba Y, Sakamoto Y, Ohuchi M, Tokunaga R, Kurashige J, Hiyoshi Y, Iwagami S, Yoshida N, Watanabe M, Baba H (2015) Negative impact of skeletal muscle loss after systemic chemotherapy in patients with unresectable colorectal cancer. PLoS One 10 e0129742 Miyamoto Y, Baba Y, Sakamoto Y, Ohuchi M, Tokunaga R, Kurashige J, Hiyoshi Y, Iwagami S, Yoshida N, Watanabe M, Baba H (2015) Negative impact of skeletal muscle loss after systemic chemotherapy in patients with unresectable colorectal cancer. PLoS One 10 e0129742
18.
Zurück zum Zitat Toyokawa TKN, Shibutani M, Sakurai K, Nagahara H, Tanaka H, Muguruma K, Ohtani H, Yashiro M, Maeda K, Ohira M, Hirakawa K (2015) The pretreatment controlling nutritional status (CONUT) score as an independent prognostic factor in patients with clinical stage I-III esophageal squamous cell carcinoma. Ann Oncol 26(Supplement 4):iv1–iv100 Toyokawa TKN, Shibutani M, Sakurai K, Nagahara H, Tanaka H, Muguruma K, Ohtani H, Yashiro M, Maeda K, Ohira M, Hirakawa K (2015) The pretreatment controlling nutritional status (CONUT) score as an independent prognostic factor in patients with clinical stage I-III esophageal squamous cell carcinoma. Ann Oncol 26(Supplement 4):iv1–iv100
19.
Zurück zum Zitat Iseki Y, Shibutani M, Maeda K, Nagahara H, Ohtani H, Sugano K, Ikeya T, Muguruma K, Tanaka H, Toyokawa T, Sakurai K, Hirakawa K (2015) Impact of the preoperative controlling nutritional status (CONUT) score on the survival after curative surgery for colorectal cancer. PLoS One 10 e0132488 Iseki Y, Shibutani M, Maeda K, Nagahara H, Ohtani H, Sugano K, Ikeya T, Muguruma K, Tanaka H, Toyokawa T, Sakurai K, Hirakawa K (2015) Impact of the preoperative controlling nutritional status (CONUT) score on the survival after curative surgery for colorectal cancer. PLoS One 10 e0132488
20.
Zurück zum Zitat Cengiz O, Kocer B, Surmeli S, Santicky MJ, Soran A (2006) Are pretreatment serum albumin and cholesterol levels prognostic tools in patients with colorectal carcinoma? Med Sci Monit 12:CR240–CR247PubMed Cengiz O, Kocer B, Surmeli S, Santicky MJ, Soran A (2006) Are pretreatment serum albumin and cholesterol levels prognostic tools in patients with colorectal carcinoma? Med Sci Monit 12:CR240–CR247PubMed
21.
Zurück zum Zitat Peters SJ, Vanhaecke T, Papeleu P, Rogiers V, Haagsman HP, van Norren K (2010) Co-culture of primary rat hepatocytes with rat liver epithelial cells enhances interleukin-6-induced acute-phase protein response. Cell Tissue Res 340:451–457CrossRefPubMedPubMedCentral Peters SJ, Vanhaecke T, Papeleu P, Rogiers V, Haagsman HP, van Norren K (2010) Co-culture of primary rat hepatocytes with rat liver epithelial cells enhances interleukin-6-induced acute-phase protein response. Cell Tissue Res 340:451–457CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Honda H, Qureshi AR, Heimburger O, Barany P, Wang K, Pecoits-Filho R, Stenvinkel P, Lindholm B (2006) Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis 47:139–148CrossRefPubMed Honda H, Qureshi AR, Heimburger O, Barany P, Wang K, Pecoits-Filho R, Stenvinkel P, Lindholm B (2006) Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis 47:139–148CrossRefPubMed
23.
Zurück zum Zitat Sonoda A, Ohnishi S, Nakao S, Iwashita Y, Hashimoto N, Ishida K, Kondo Y, Ishitsuka Y, Irie T (2015) Factors affecting serum albumin in the perioperative period of colorectal surgery: a retrospective study. BMC Res Notes 8:638CrossRefPubMedPubMedCentral Sonoda A, Ohnishi S, Nakao S, Iwashita Y, Hashimoto N, Ishida K, Kondo Y, Ishitsuka Y, Irie T (2015) Factors affecting serum albumin in the perioperative period of colorectal surgery: a retrospective study. BMC Res Notes 8:638CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Domenicali M, Baldassarre M, Giannone FA, Naldi M, Mastroroberto M, Biselli M, Laggetta M, Patrono D, Bertucci C, Bernardi M, Caraceni P (2014) Posttranscriptional changes of serum albumin: clinical and prognostic significance in hospitalized patients with cirrhosis. Hepatology 60:1851–1860CrossRefPubMed Domenicali M, Baldassarre M, Giannone FA, Naldi M, Mastroroberto M, Biselli M, Laggetta M, Patrono D, Bertucci C, Bernardi M, Caraceni P (2014) Posttranscriptional changes of serum albumin: clinical and prognostic significance in hospitalized patients with cirrhosis. Hepatology 60:1851–1860CrossRefPubMed
25.
Zurück zum Zitat Okuyama H, Ichikawa Y, Sun Y, Hamazaki T, Lands WE (2007) Cancer and all-cause mortalities are lower in the higher total cholesterol groups among general populations. World Rev Nutr Diet 96:37–54PubMed Okuyama H, Ichikawa Y, Sun Y, Hamazaki T, Lands WE (2007) Cancer and all-cause mortalities are lower in the higher total cholesterol groups among general populations. World Rev Nutr Diet 96:37–54PubMed
26.
Zurück zum Zitat Kreger BE, Anderson KM, Schatzkin A, Splansky GL (1992) Serum cholesterol level, body mass index, and the risk of colon cancer. The Framingham study. Cancer 70:1038–1043CrossRefPubMed Kreger BE, Anderson KM, Schatzkin A, Splansky GL (1992) Serum cholesterol level, body mass index, and the risk of colon cancer. The Framingham study. Cancer 70:1038–1043CrossRefPubMed
27.
Zurück zum Zitat de Martino M, Leitner CV, Seemann C, Hofbauer SL, Lucca I, Haitel A, Shariat SF, Klatte T (2015) Preoperative serum cholesterol is an independent prognostic factor for patients with renal cell carcinoma (RCC). BJU Int 115:397–404CrossRefPubMed de Martino M, Leitner CV, Seemann C, Hofbauer SL, Lucca I, Haitel A, Shariat SF, Klatte T (2015) Preoperative serum cholesterol is an independent prognostic factor for patients with renal cell carcinoma (RCC). BJU Int 115:397–404CrossRefPubMed
28.
Zurück zum Zitat Niendorf A, Nagele H, Gerding D, Meyer-Pannwitt U, Gebhardt A (1995) Increased LDL receptor mRNA expression in colon cancer is correlated with a rise in plasma cholesterol levels after curative surgery. Int J Cancer 61:461–464CrossRefPubMed Niendorf A, Nagele H, Gerding D, Meyer-Pannwitt U, Gebhardt A (1995) Increased LDL receptor mRNA expression in colon cancer is correlated with a rise in plasma cholesterol levels after curative surgery. Int J Cancer 61:461–464CrossRefPubMed
29.
Zurück zum Zitat Cardwell CR, Hicks BM, Hughes C, Murray LJ (2014) Statin use after colorectal cancer diagnosis and survival: a population-based cohort study. J Clin Oncol 32:3177–3183CrossRefPubMed Cardwell CR, Hicks BM, Hughes C, Murray LJ (2014) Statin use after colorectal cancer diagnosis and survival: a population-based cohort study. J Clin Oncol 32:3177–3183CrossRefPubMed
30.
Zurück zum Zitat Nielsen SF, Nordestgaard BG, Bojesen SE (2012) Statin use and reduced cancer-related mortality. N Engl J Med 367:1792–1802CrossRefPubMed Nielsen SF, Nordestgaard BG, Bojesen SE (2012) Statin use and reduced cancer-related mortality. N Engl J Med 367:1792–1802CrossRefPubMed
31.
Zurück zum Zitat Liang L, Zhu J, Jia H, Huang L, Li D, Li Q, Li X (2016) Predictive value of pretreatment lymphocyte count in stage II colorectal cancer and in high-risk patients treated with adjuvant chemotherapy. Oncotarget 7(1):1014–1028PubMed Liang L, Zhu J, Jia H, Huang L, Li D, Li Q, Li X (2016) Predictive value of pretreatment lymphocyte count in stage II colorectal cancer and in high-risk patients treated with adjuvant chemotherapy. Oncotarget 7(1):1014–1028PubMed
32.
Zurück zum Zitat Network CGA (2012) Comprehensive molecular characterization of human colon and rectal cancer. Nature 487:330–337CrossRef Network CGA (2012) Comprehensive molecular characterization of human colon and rectal cancer. Nature 487:330–337CrossRef
33.
Zurück zum Zitat Moyes LH, Leitch EF, McKee RF, Anderson JH, Horgan PG, McMillan DC (2009) Preoperative systemic inflammation predicts postoperative infectious complications in patients undergoing curative resection for colorectal cancer. Br J Cancer 100:1236–1239CrossRefPubMedPubMedCentral Moyes LH, Leitch EF, McKee RF, Anderson JH, Horgan PG, McMillan DC (2009) Preoperative systemic inflammation predicts postoperative infectious complications in patients undergoing curative resection for colorectal cancer. Br J Cancer 100:1236–1239CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Andreyev HJ, Norman AR, Oates J, Cunningham D (1998) Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? Eur J Cancer 34:503–509CrossRefPubMed Andreyev HJ, Norman AR, Oates J, Cunningham D (1998) Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? Eur J Cancer 34:503–509CrossRefPubMed
35.
Zurück zum Zitat Fearon KC, Voss AC, Hustead DS (2006) Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Am J Clin Nutr 83:1345–1350PubMed Fearon KC, Voss AC, Hustead DS (2006) Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Am J Clin Nutr 83:1345–1350PubMed
Metadaten
Titel
CONUT: a novel independent predictive score for colorectal cancer patients undergoing potentially curative resection
verfasst von
Ryuma Tokunaga
Yasuo Sakamoto
Shigeki Nakagawa
Mayuko Ohuchi
Daisuke Izumi
Keisuke Kosumi
Katsunobu Taki
Takaaki Higashi
Yuji Miyamoto
Naoya Yoshida
Eiji Oki
Masayuki Watanabe
Hideo Baba
Publikationsdatum
10.10.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
International Journal of Colorectal Disease / Ausgabe 1/2017
Print ISSN: 0179-1958
Elektronische ISSN: 1432-1262
DOI
https://doi.org/10.1007/s00384-016-2668-5

Weitere Artikel der Ausgabe 1/2017

International Journal of Colorectal Disease 1/2017 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.